Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-28T13:33:08.949Z Has data issue: false hasContentIssue false

Chapter 67 - Anthrax

Published online by Cambridge University Press:  23 July 2018

By
David M. Stier ,
Mary P. Mercer  and
Rachel L. Chin
Edited by
Rachel L. Chin ,
Bradley W. Frazee  and
Zlatan Coralic
Rachel L. Chin
Affiliation:
University of California, San Francisco School of Medicine
Bradley W. Frazee
Affiliation:
University of California, San Francisco School of Medicine
Zlatan Coralic
Affiliation:
University of California, San Francisco
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Emergency Management of Infectious Diseases , pp. 480 - 489
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Bales, M. E., Dannenberg, A. L., Brachman, P. S., et al. Epidemiologic response to anthrax outbreaks: field investigations, 1950–2001. Emerg. Infect. Dis. 2002; 8(10): 1163–74.CrossRefGoogle ScholarPubMed
Bell, D. M., Kozarsky, P. E., and Stephens, D. S. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg. Infect. Dis. 2002; 8(2): 222–5.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention (CDC). Anthrax, available at www.cdc.gov/anthrax/ (accessed March 9, 2018).Google Scholar
CDC. Inhalation anthrax associated with dried animal hides – Pennsylvania and New York City, 2006. MMWR Morb. Mortal. Wkly. Rep. 2006; 55(10): 280–2.Google Scholar
CDC. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb. Mortal. Wkly. Rep. 2001; 50(42): 909–19.Google Scholar
CDC. Suspected cutaneous anthrax in a laboratory worker – Texas 2002. MMWR Morb. Mortal. Wkly. Rep. 2002; 51(13): 279–81.Google Scholar
CDC. Use of Anthrax vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb. Mortal. Wkly. Rep. 2010; 59(RR06): 1–30.Google Scholar
CDC. Considerations for anthrax vaccine absorbed (AVA) postexposure prioritization final (2013), available at www.cdc.gov/anthrax/medical-care/prevention.html (accessed March 19, 2018).Google Scholar
Food and Drug Administration (FDA). Anthrasil [anthrax immune globulin intravenous (human)] www.fda.gov/biologicsbloodvaccines/bloodbloodproducts/approvedproducts/licensedproductsblas/fractionatedplasmaproducts/ucm441234.htm (accessed March 19, 2018).Google Scholar
FDA. Raxibacumab (2012), retrieved March 19, 2018, from www.accessdata.fda.gov/drugsatfda_docs/label/2012/125349s000lbl.pdf.Google Scholar
Freedman, A., Afonja, O., Chang, M. W., et al. Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002; 287(7): 869–74.CrossRefGoogle Scholar
Hendricks, K. A., Wright, M. E., Shadomy, S. V., et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg. Infect. Dis. 2014, available at http://dx.doi.org/10.3201/eid2002.130687 (accessed March 20, 2018).CrossRefGoogle Scholar
Holty, J. E., Kim, R. Y., and Bravata, D. M. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann. Intern. Med. 2006; 144(4): 270–80.CrossRefGoogle ScholarPubMed
Howell, J. M., Mayer, T. A., Hanfling, D., et al. Screening for inhalational anthrax due to bioterrorism: evaluating proposed screening protocols. Clin. Infect. Dis. 2004; 39(12): 1842–7.CrossRefGoogle ScholarPubMed
Huang, E., Pillai, S. K., Bower, W. A., et. al. Antitoxin treatment of inhalation anthrax: a systematic review. Health Security. 2015; 13(6): 365–77.CrossRefGoogle ScholarPubMed
Jernigan, J. A., Stephens, D. S., Ashford, D. A., et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 2001; 7(6): 933–44.CrossRefGoogle ScholarPubMed
Kadanali, A., Tasyaran, M. A., and Kadanali, S. Anthrax during pregnancy: case reports and review. Clin. Infect. Dis. 2003; 36(10): 1343–6.CrossRefGoogle ScholarPubMed
Meaney-Delmam, D., Zotti, M. E., Creanga, A. A., et al. Centers for Disease Control and Prevention. Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women. Emerg. Infect. Dis. 2014, available at wwwnc.cdc.gov/eid/article/20/2/13-0611_article (accessed March 20, 2018).CrossRefGoogle Scholar
Meyerhoff, A. and Murphy, D. Guidelines for treatment of anthrax. JAMA 2002; 288(15): 1848–9; author reply 1848–9.22.CrossRefGoogle ScholarPubMed
Sejvar, J. J., Tenover, F. C., and Stephens, D. S. Management of anthrax meningitis. Lancet Infect. Dis. 2005; 5(5): 287–95.CrossRefGoogle ScholarPubMed
Sirisanthana, T. and Brown, A. E. Anthrax of the gastrointestinal tract. Emerg. Infect. Dis. 2002; 8(7): 649–51.CrossRefGoogle ScholarPubMed
Swartz, M. N. Recognition and management of anthrax – an update. N. Engl. J. Med. 2001; 345(22): 1621–6.CrossRefGoogle ScholarPubMed
Center for Infectious Disease Research and Policy. Anthrax: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis (CIDRAP, 2006), retrieved March 20, 2018 from www.cidrap.umn.edu/infectious-disease-topics/anthrax.Google Scholar
Dixon, T. C., Meselson, M., Guillemin, J., et al. Anthrax. N. Engl. J. Med. 1999; 341(11): 815–26.CrossRefGoogle ScholarPubMed
Inglesby, T. V., O’Toole, T., Henderson, D. A., et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287(17): 2236–52.CrossRefGoogle ScholarPubMed
Martin, G. J. and Friedlander, A. M. Bacillus anthracis (anthrax) in Bennett, J. E., Dolin, R., and Blaser, M. J. (eds.), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn. (Philadelphia, PA: Elsevier/Saunders, 2015), pp. 2391–409.Google Scholar
Center for Infectious Disease Research and Policy. Anthrax: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis (CIDRAP, 2006), retrieved March 20, 2018 from www.cidrap.umn.edu/infectious-disease-topics/anthrax.Google Scholar
Dixon, T. C., Meselson, M., Guillemin, J., et al. Anthrax. N. Engl. J. Med. 1999; 341(11): 815–26.CrossRefGoogle ScholarPubMed
Inglesby, T. V., O’Toole, T., Henderson, D. A., et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287(17): 2236–52.CrossRefGoogle ScholarPubMed
Martin, G. J. and Friedlander, A. M. Bacillus anthracis (anthrax) in Bennett, J. E., Dolin, R., and Blaser, M. J. (eds.), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn. (Philadelphia, PA: Elsevier/Saunders, 2015), pp. 2391–409.Google Scholar

Additional Readings

Center for Infectious Disease Research and Policy. Anthrax: current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis (CIDRAP, 2006), retrieved March 20, 2018 from www.cidrap.umn.edu/infectious-disease-topics/anthrax.Google Scholar
Dixon, T. C., Meselson, M., Guillemin, J., et al. Anthrax. N. Engl. J. Med. 1999; 341(11): 815–26.CrossRefGoogle ScholarPubMed
Inglesby, T. V., O’Toole, T., Henderson, D. A., et al. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002; 287(17): 2236–52.CrossRefGoogle ScholarPubMed
Martin, G. J. and Friedlander, A. M. Bacillus anthracis (anthrax) in Bennett, J. E., Dolin, R., and Blaser, M. J. (eds.), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn. (Philadelphia, PA: Elsevier/Saunders, 2015), pp. 2391–409.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×